| Product Code: ETC12962862 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The import shipments of naltrexone and buprenorphine to Ireland experienced significant growth in 2024, with the top exporting countries being Germany, UK, USA, Canada, and Areas, nes. The market showed a high concentration level in 2024 compared to moderate concentration in 2023, indicating increased dominance of key players. The compound annual growth rate (CAGR) from 2020 to 2024 was a robust 23.25%, with a notable growth rate of 68.68% from 2023 to 2024. This suggests a rapidly expanding market for naltrexone and buprenorphine in Ireland, driven by a strong demand for these pharmaceutical products.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Naltrexone Buprenorphine Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Naltrexone Buprenorphine Market Revenues & Volume, 2022 & 2032F |
3.3 Ireland Naltrexone Buprenorphine Market - Industry Life Cycle |
3.4 Ireland Naltrexone Buprenorphine Market - Porter's Five Forces |
3.5 Ireland Naltrexone Buprenorphine Market Revenues & Volume Share, By Formulation Type, 2022 & 2032F |
3.6 Ireland Naltrexone Buprenorphine Market Revenues & Volume Share, By Mechanism of Action, 2022 & 2032F |
3.7 Ireland Naltrexone Buprenorphine Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Ireland Naltrexone Buprenorphine Market Revenues & Volume Share, By Administration Method, 2022 & 2032F |
3.9 Ireland Naltrexone Buprenorphine Market Revenues & Volume Share, By Patient Group, 2022 & 2032F |
4 Ireland Naltrexone Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of medication-assisted treatment (MAT) for opioid addiction in Ireland |
4.2.2 Government initiatives and policies promoting the use of naltrexone and buprenorphine for opioid dependence |
4.2.3 Growing prevalence of opioid addiction and related health issues in Ireland |
4.3 Market Restraints |
4.3.1 Regulatory challenges and restrictions related to the prescription and distribution of naltrexone and buprenorphine |
4.3.2 Limited availability and accessibility of MAT programs in some regions of Ireland |
4.3.3 Stigma and misconceptions associated with medication-based treatments for opioid addiction |
5 Ireland Naltrexone Buprenorphine Market Trends |
6 Ireland Naltrexone Buprenorphine Market, By Types |
6.1 Ireland Naltrexone Buprenorphine Market, By Formulation Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Formulation Type, 2022 - 2032F |
6.1.3 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Oral Tablet, 2022 - 2032F |
6.1.4 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Sublingual Film, 2022 - 2032F |
6.1.5 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Injectable Form, 2022 - 2032F |
6.1.6 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Implant, 2022 - 2032F |
6.1.7 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Combination Form, 2022 - 2032F |
6.2 Ireland Naltrexone Buprenorphine Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Opioid Receptor Modulation, 2022 - 2032F |
6.2.3 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Partial Agonist, 2022 - 2032F |
6.2.4 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Long-Acting Effect, 2022 - 2032F |
6.2.5 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Sustained Release, 2022 - 2032F |
6.2.6 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Dual Mechanism, 2022 - 2032F |
6.3 Ireland Naltrexone Buprenorphine Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Opioid Dependence, 2022 - 2032F |
6.3.3 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Withdrawal Management, 2022 - 2032F |
6.3.4 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Relapse Prevention, 2022 - 2032F |
6.3.5 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Maintenance Therapy, 2022 - 2032F |
6.3.6 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Detoxification, 2022 - 2032F |
6.4 Ireland Naltrexone Buprenorphine Market, By Administration Method |
6.4.1 Overview and Analysis |
6.4.2 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Oral, 2022 - 2032F |
6.4.3 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Sublingual, 2022 - 2032F |
6.4.4 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Injection, 2022 - 2032F |
6.4.5 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Subcutaneous, 2022 - 2032F |
6.4.6 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Oral, 2022 - 2032F |
6.5 Ireland Naltrexone Buprenorphine Market, By Patient Group |
6.5.1 Overview and Analysis |
6.5.2 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Adults, 2022 - 2032F |
6.5.3 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Teenagers, 2022 - 2032F |
6.5.4 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Elderly, 2022 - 2032F |
6.5.5 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By Critical Patients, 2022 - 2032F |
6.5.6 Ireland Naltrexone Buprenorphine Market Revenues & Volume, By All Ages, 2022 - 2032F |
7 Ireland Naltrexone Buprenorphine Market Import-Export Trade Statistics |
7.1 Ireland Naltrexone Buprenorphine Market Export to Major Countries |
7.2 Ireland Naltrexone Buprenorphine Market Imports from Major Countries |
8 Ireland Naltrexone Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare providers trained in prescribing and administering naltrexone and buprenorphine |
8.2 Percentage of opioid addiction patients opting for MAT with naltrexone or buprenorphine |
8.3 Patient retention rates in naltrexone and buprenorphine treatment programs |
9 Ireland Naltrexone Buprenorphine Market - Opportunity Assessment |
9.1 Ireland Naltrexone Buprenorphine Market Opportunity Assessment, By Formulation Type, 2022 & 2032F |
9.2 Ireland Naltrexone Buprenorphine Market Opportunity Assessment, By Mechanism of Action, 2022 & 2032F |
9.3 Ireland Naltrexone Buprenorphine Market Opportunity Assessment, By Application, 2022 & 2032F |
9.4 Ireland Naltrexone Buprenorphine Market Opportunity Assessment, By Administration Method, 2022 & 2032F |
9.5 Ireland Naltrexone Buprenorphine Market Opportunity Assessment, By Patient Group, 2022 & 2032F |
10 Ireland Naltrexone Buprenorphine Market - Competitive Landscape |
10.1 Ireland Naltrexone Buprenorphine Market Revenue Share, By Companies, 2025 |
10.2 Ireland Naltrexone Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here